Literature DB >> 31848320

Genetic diversity affects the nanoscale membrane organization and signaling of natural killer cell receptors.

Philippa R Kennedy1, Charlotte Barthen1, David J Williamson1, William T E Pitkeathly1, Khodor S Hazime1, Joshua Cumming1, Kevin B Stacey1, Hugo G Hilton2, Mary Carrington3,4, Peter Parham2, Daniel M Davis5.   

Abstract

Genetic diversity in human natural killer (NK) cell receptors is linked to resistance and susceptibility to many diseases. Here, we tested the effect of this diversity on the nanoscale organization of killer cell immunoglobulin-like receptors (KIRs). Using superresolution microscopy, we found that inhibitory KIRs encoded by different genes and alleles were organized differently at the surface of primary human NK cells. KIRs that were found at low abundance assembled into smaller clusters than those formed by KIRs that were more highly abundant, and at low abundance, there was a greater proportion of KIRs in clusters. Upon receptor triggering, a structured interface called the immune synapse assembles, which facilitates signal integration and controls NK cell responses. Here, triggering of low-abundance receptors resulted in less phosphorylation of the downstream phosphatase SHP-1 but more phosphorylation of the adaptor protein Crk than did triggering of high-abundance receptors. In cells with greater KIR abundance, SHP-1 dephosphorylated Crk, which potentiated NK cell spreading during activation. Thus, genetic variation modulates both the abundance and nanoscale organization of inhibitory KIRs. That is, as well as the number of receptors at the cell surface varying with genotype, the way in which these receptors are organized in the membrane also varies. Essentially, a change in the average surface abundance of a protein at the cell surface is a coarse descriptor entwined with changes in local nanoscale clustering. Together, our data indicate that genetic diversity in inhibitory KIRs affects membrane-proximal signaling and, unexpectedly, the formation of activating immune synapses.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31848320      PMCID: PMC6944503          DOI: 10.1126/scisignal.aaw9252

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  61 in total

1.  The human natural killer cell immune synapse.

Authors:  D M Davis; I Chiu; M Fassett; G B Cohen; O Mandelboim; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Superresolution microscopy reveals nanometer-scale reorganization of inhibitory natural killer cell receptors upon activation of NKG2D.

Authors:  Sophie V Pageon; Shaun-Paul Cordoba; Dylan M Owen; Stephen M Rothery; Anna Oszmiana; Daniel M Davis
Journal:  Sci Signal       Date:  2013-07-23       Impact factor: 8.192

3.  Quantitative comparison of spot detection methods in fluorescence microscopy.

Authors:  Ihor Smal; Marco Loog; Wiro Niessen; Erik Meijering
Journal:  IEEE Trans Med Imaging       Date:  2009-06-23       Impact factor: 10.048

4.  Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance.

Authors:  Sophie Guia; Baptiste N Jaeger; Stefan Piatek; Sébastien Mailfert; Tomasz Trombik; Aurore Fenis; Nicolas Chevrier; Thierry Walzer; Yann M Kerdiles; Didier Marguet; Eric Vivier; Sophie Ugolini
Journal:  Sci Signal       Date:  2011-04-05       Impact factor: 8.192

5.  TrackMate: An open and extensible platform for single-particle tracking.

Authors:  Jean-Yves Tinevez; Nick Perry; Johannes Schindelin; Genevieve M Hoopes; Gregory D Reynolds; Emmanuel Laplantine; Sebastian Y Bednarek; Spencer L Shorte; Kevin W Eliceiri
Journal:  Methods       Date:  2016-10-03       Impact factor: 3.608

Review 6.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

7.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Fotini Partheniou; Ann-Margaret Little; Peter Parham
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

8.  Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.

Authors:  Mary E Peterson; Eric O Long
Journal:  Immunity       Date:  2008-10-02       Impact factor: 31.745

9.  Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.

Authors:  Hathairat Thananchai; Geraldine Gillespie; Maureen P Martin; Arman Bashirova; Nobuyo Yawata; Makoto Yawata; Philippa Easterbrook; Daniel W McVicar; Katsumi Maenaka; Peter Parham; Mary Carrington; Tao Dong; Sarah Rowland-Jones
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

10.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Ann-Margaret Little; Fotini Partheniou; Peter Parham
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  3 in total

1.  Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.

Authors:  Kirsten M Anderson; Danillo G Augusto; Ravi Dandekar; Hengameh Shams; Chao Zhao; Tasneem Yusufali; Gonzalo Montero-Martín; Wesley M Marin; Neda Nemat-Gorgani; Lisa E Creary; Stacy Caillier; Mohammad R K Mofrad; Peter Parham; Marcelo Fernández-Viña; Jorge R Oksenberg; Paul J Norman; Jill A Hollenbach
Journal:  J Immunol       Date:  2020-07-24       Impact factor: 5.422

2.  Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.

Authors:  Dhon Roméo Makanga; Maxime Jullien; Gaëlle David; Nolwenn Legrand; Catherine Willem; Léa Dubreuil; Alexandre Walencik; Cyrille Touzeau; Thomas Gastinne; Benoit Tessoulin; Steven Le Gouill; Béatrice Mahé; Katia Gagne; Patrice Chevallier; Béatrice Clemenceau; Christelle Retière
Journal:  Oncoimmunology       Date:  2021-06-14       Impact factor: 8.110

Review 3.  Licensing Natural Killers for Antiviral Immunity.

Authors:  John M Cronk; Eleni Fafoutis; Michael G Brown
Journal:  Pathogens       Date:  2021-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.